Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2008
11/04/2008US7446205 Method for making nicotine hapten
11/04/2008US7446199 Compositions useful as inhibitors of protein kinases
11/04/2008US7446122 Substituted indole derivatives
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
11/04/2008US7446110 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; benign prostate hyperplasia, depression, sexual dysfuction, sleep apnea; ideal for hormone replacement therapy in hypogonadic men
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
10/2008
10/30/2008WO2008131276A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008WO2008131253A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008WO2008131227A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008WO2008131000A2 7-substituted indole mcl-1 inhibitors
10/30/2008WO2008130944A1 Solid phase syntheses of amino pyrimidine compounds
10/30/2008WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008WO2008130853A1 Hydrazides and their use as metabotropic glutamate receptor potentiators - 681
10/30/2008WO2008130651A2 Diarylisoxazolines
10/30/2008WO2008130584A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008WO2008130581A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008WO2008130313A1 Imidazole derivatives as modulators of the gaba receptor for the treatment of gastrointestinal disorders
10/30/2008WO2008130312A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
10/30/2008WO2008130021A2 Heterocyclic hydrazide compound and pesticidal use of the same
10/30/2008WO2008129912A1 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
10/30/2008WO2008129380A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
10/30/2008WO2008129157A2 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
10/30/2008WO2008129080A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
10/30/2008WO2008129075A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds
10/30/2008WO2008129054A2 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008WO2008128995A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128994A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128984A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128968A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
10/30/2008WO2008128919A2 Histamine h3 receptor ligands comprising a cyclobutoxy group
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128711A1 Insecticidal aryl pyrrolidines
10/30/2008WO2008128647A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008WO2008106692B1 Pim kinase inhibitors and methods of their use
10/30/2008WO2008061112A3 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
10/30/2008WO2008030408A3 Proteomimetic compounds as inhibitors of the interaction of a nuclear receptor with coactivator peptides
10/30/2008WO2008021049A2 Crystalline antifungal compounds
10/30/2008WO2008011130A3 Amide compounds
10/30/2008WO2007126362A8 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
10/30/2008WO2007109211A8 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/30/2008US20080269497 Crystals of benzimidizoles formed by isolation of base and water soluble base; final intermediate for the production of antiulceratives, in particular omeprazole or lanzoprazole
10/30/2008US20080269488 Characterized by x-ray reflections at 8.4 degrees, 10.8 degrees, 20.0 degrees, 20.4 degrees, and 21.2 degrees +-0.2 degrees 2 theta.
10/30/2008US20080269487 6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline; prevent, treat tumours which are sensitive to inhibition of erbB receptor tyrosine kinases
10/30/2008US20080269297 Dissolving base addition salt of esomeprazole in water containing at least one amine, adding at least one acid, allowing esomeprazole non-salt form to crystallize and isolating the formed crystals; for treatment of gastrointestinal disorders
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269294 Benzamide Compounds Useful as Histone Deacetylase Inhibitors
10/30/2008US20080269293 1-[2-(5-Methyl-2-o-tolyl-2H-pyrazol-3-yloxy)-phenyl]-3-(4-trifluoromethoxy-phenyl)-urea, for example; useful as P2Y1 antagonists for treating thromboembolic disorders
10/30/2008US20080269291 Chemical Compounds
10/30/2008US20080269288 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome
10/30/2008US20080269284 e.g. 4-[(3,5-bistrifluoromethylbenzyl)-(2-propyl-2H-tetrazol-5-yl)amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis
10/30/2008US20080269280 Antiinflammatory agents; rheumatic diseases; multiple sclerosis
10/30/2008US20080269269 Protein kinase inhibitor; purity; polymorphism
10/30/2008US20080269268 Substituted Phenylamino-Pyrimidines
10/30/2008US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders
10/30/2008US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080269256 Central nervous system disorders; antidepressants;anxiolytic agents; psychological disorders; antiepileptic agents; schizophrenia; Alzheimer's disease; antiischemic agents; antiepileptic agents
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269244 Suppression cytokines , tumor necrosis factor
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269233 Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269215 Bisamide Inhibitors of Hedgehog Signaling
10/30/2008US20080269214 Therapy for bacteria infections
10/30/2008US20080269213 8-Hydroxyquinoline compounds and methods thereof
10/30/2008US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269200 Antiinflammatory agents; tissue repair; rheumatic disorders; asthma; chronic onstructive pulmonary disease; osteoporosis; psoriasis; Alzheimer's disease; transplant rejection; stroke; antidiabetic agents; glomerulonephritis; anticancer agents
10/30/2008US20080269199 Therapy for obesity, diabetes, sleep disorders, Alzheimer's disease, Parkinson's disease; attention deficit disorders; antiepileptic agents; schizophrenia; antidepressants; anxiolytic agents
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269170 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors
10/30/2008US20080269143 Dual delta and mu opioid receptor antagonist; 3,6-Bis(Boc-Dmt-Tic-NH-methyl)-2(1H)-pyrazinone
10/30/2008US20080269059 Pyridinecarboxamides, useful-plant-protecting composition comprising them and processes for their prepartion and their use
10/30/2008US20080268749 Crotch-Possessing Corrective Garment
10/30/2008US20080268283 Aromatic amine derivative and organic electroluminescence device employing the same
10/30/2008US20080268040 Organic Compounds Comprising a Glycopyrrolium Salt
10/30/2008US20080267981 Treating neoplastic diseases with antibody-cytotoxin conjugate (duocarmycins); integrins; 3-[5-(1-(3-aminopropyl)indole-2-carbonyl)aminoindole-2-carbonyl]-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole
10/30/2008US20080267883 Comprises carboxyl or carbonyl functionalized pyridine moiety; bioconjugation; biocompatability; in vivo optical imaging
10/30/2008US20080267870 1-[(2'-Substituted)-piperazin-1' -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008US20080263787 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds
10/30/2008US20080263785 Hair affinity; light and shampooing fastness; such as 1-(6-{3-[4-(1H-imidazol-1-yl)butyl]-1H-imidazol-3-ium-1-yl}hexyl)-4-{[methyl(phenyl)hydrazono]methyl}quinolinium dibromide; multicompartment cosmetic kits
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2684950A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008CA2684949A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008CA2684651A1 Insecticidal aryl pyrrolidines
10/30/2008CA2684644A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008CA2684634A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684633A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684552A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
10/30/2008CA2684347A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 1080